Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0770
0.00 (0.00%)
Jan 30, 2026, 3:58 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 22.5 million as of January 29, 2026. Its market cap has decreased by -21.43% in one year.
Market Cap
22.50M
Enterprise Value
23.43M
Revenue
2.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 22.50M, an increase of 61.81%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 22.50M | -17.20% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 51.57M |
| NeuroScientific Biopharmaceuticals | 49.89M |
| Algorae Pharmaceuticals | 37.15M |
| Avecho Biotechnology | 36.73M |
| Argenica Therapeutics | 32.76M |
| Neurotech International | 20.74M |
| Tissue Repair | 19.35M |
| Immuron | 12.04M |